ARCHIVES

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

ASCO, FDA Website To Help Demystify Expanded Access

June 25, 2010

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985